Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I/II study of intraperitoneal mitoxantrone in refractory ovarian cancer.
Oza AM, ten Bokkel Huinink W, Dubbelman R, Soepenberg O, Mandjes I, Aartsen E, McVie JG. Oza AM, et al. Among authors: ten bokkel huinink w. Ann Oncol. 1994 Apr;5(4):343-7. doi: 10.1093/oxfordjournals.annonc.a058838. Ann Oncol. 1994. PMID: 8075031 Free article. Clinical Trial.
Pharmacokinetics of carboplatin after intraperitoneal administration.
Elferink F, van der Vijgh WJ, Klein I, ten Bokkel Huinink WW, Dubbelman R, McVie JG. Elferink F, et al. Among authors: ten bokkel huinink ww. Cancer Chemother Pharmacol. 1988;21(1):57-60. doi: 10.1007/BF00262740. Cancer Chemother Pharmacol. 1988. PMID: 3277734
Pharmacokinetics of paclitaxel and three major metabolites in patients with advanced breast carcinoma refractory to anthracycline therapy treated with a 3-hour paclitaxel infusion: a European Cancer Centre (ECC) trial.
Huizing MT, Vermorken JB, Rosing H, ten Bokkel Huinink WW, Mandjes I, Pinedo HM, Beijnen JH. Huizing MT, et al. Among authors: ten bokkel huinink ww. Ann Oncol. 1995 Sep;6(7):699-704. doi: 10.1093/oxfordjournals.annonc.a059287. Ann Oncol. 1995. PMID: 8664192 Free article. Clinical Trial.
Replacement of cisplatin with carboplatin in combination chemotherapy against ovarian cancer: long-term treatment results of a study of the Gynaecological Cancer Cooperative Group of the EORTC and experience at The Netherlands Cancer Institute.
ten Bokkel Huinink WW, Dalesio O, Rodenhuis S, Dubbelman R, Hilton A, Franklin H, Koier I, van Tinteren H, van der Burg ME, van Oosterom AT, et al. ten Bokkel Huinink WW, et al. Semin Oncol. 1992 Feb;19(1 Suppl 2):99-101. Semin Oncol. 1992. PMID: 1411634 Clinical Trial.
243 results